Cormorant Asset Management »

Engene Holdings shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Engene Holdings (ENGN) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Engene Holdings

Tip: Access up to 7 years of quarterly data

All positions including Engene Holdings held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Holdings by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 2.3M 6.83
2025-06-30 $8.5M 2.3M 3.64
2025-03-31 $10M 2.3M 4.48
2024-12-31 $16M 2.3M 6.65
2024-09-30 $6.6M 1.0M 6.60
2024-06-30 $9.4M 1.0M 9.43
2024-03-31 $17M 1.0M 16.95

More positions owned by Cormorant Asset Management

Bridgebio Oncology Therapeut Com New
Abivax Sa Sponsored Ads (ABVX)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Edgewise Therapeutics (EWTX)
Bright Minds Biosciences Com New (DRUG)
Arcellx Common Stock (ACLX)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Praxis Precision Medicines I Com New (PRAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Gh Research Ordinary Shares (GHRS)

View all positions for Cormorant Asset Management

Top funds holding Engene Holdings

Fcpm Iii Services B.v.
VR Adviser
Kynam Capital Management
Blue Owl Capital Holdings
Cormorant Asset Management
Braidwell
Deep Track Capital
Perceptive Advisors
Point72 Asset Management
Frazier Life Sciences Management
Franklin Resources
Adage Capital Partners GP
Sr One Capital Management
MPM Oncology Impact Management
Omega Fund Management

View all funds holding Engene Holdings